Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate-Specific Membrane Antigen: Much More Than a Prostate Cancer Marker.

Chang1, Gaudin, Reuter

  • 1George M. O'Brien Urology Research Center, Memorial Sloan-Kettering Cancer Center, New York, New York.

Molecular Urology
|June 14, 2000
PubMed
Summary

New markers like prostate-specific membrane antigen (PSMA) are crucial for advancing prostate cancer diagnostics and therapeutics. PSMA shows promise beyond prostate tissue, appearing in tumor neovasculature, expanding its clinical potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of redox potential with state variables in cultures under controlled dissolved oxygen concentration and pH

Biotechnology progress·1998
Same author

Two p-quinonoid aporphine alkaloids from fissistigma balansae

Journal of natural products·1998
Same author

Isolation, purification, and characterization of the PR oxidase from penicillium roqueforti

Applied and environmental microbiology·1998
Same author

Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors

Chemistry & biology·1998
Same author

Inhibition of phenolic acid metabolism results in precocious cell death and altered cell morphology in leaves of transgenic tobacco plants

The Plant cell·1998
Same author

Structure and Properties of Cyano-Substituted Poly(2,5-dialkoxy-p-phenylene vinylene)s.

Macromolecules·1998

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Molecular Imaging

Background:

  • Prostate cancer remains a leading cause of cancer death in men.
  • Current markers like prostate-specific antigen (PSA) have limitations, necessitating novel diagnostic and therapeutic targets.
  • Prostate-specific membrane antigen (PSMA) is a transmembrane protein highly expressed in prostate cancer.

Purpose of the Study:

  • To evaluate prostate-specific membrane antigen (PSMA) as a novel biomarker for prostate cancer.
  • To explore the diagnostic and therapeutic potential of PSMA and its targeting agents.
  • To investigate the expanded expression of PSMA in tumor neovasculature.

Main Methods:

  • Review of existing literature on PSMA expression and its clinical applications.

Related Experiment Videos

  • Analysis of diagnostic and therapeutic trials utilizing anti-PSMA monoclonal antibodies (mAbs).
  • Examination of recent findings on PSMA expression in tumor neovasculature.

    • Main Results:

    • Anti-PSMA monoclonal antibody (mAb) 7E11 is used for diagnosing prostate cancer metastasis and recurrence.
    • Phase I and II trials show promising therapeutic results using PSMA-targeting agents.
    • PSMA is expressed in endothelial cells of tumor-associated neovasculature, broadening its utility.

    Conclusions:

    • PSMA is a valuable target for both diagnosis and therapy in prostate cancer.
    • The discovery of PSMA in tumor neovasculature significantly expands its potential clinical applications.
    • Ongoing development of anti-PSMA mAbs promises further advancements in prostate cancer management.